Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TNM Trial: Upfront Docetaxel [T] and Alternating iv and Oral Vinorelbine [N] Followed, by Either Maintenance Oral Vinorelbine, or Observation for Advanced Breast Cancer

NCT02144194 is registered in ClinicalTrials.gov with Cancer Research Group - Collaborative Group, Beirut, Lebanon. as lead sponsor.

NCT NCT02144194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02144194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TNM Trial: Upfront Docetaxel [T] and Alternating iv and Oral Vinorelbine [N] Followed, by Either Maintenance Oral Vinorelbine, or Observation for Advanced Breast Cancer
Lead sponsor
Cancer Research Group - Collaborative Group, Beirut, Lebanon.
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
December 31, 2017
Enrollment
65 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer